File:LY-334370 3D BS.png
Jump to navigation
Jump to search
Size of this preview: 800 × 519 pixels. Other resolutions: 320 × 208 pixels | 640 × 416 pixels | 1,024 × 665 pixels | 1,280 × 831 pixels | 2,700 × 1,753 pixels.
Original file (2,700 × 1,753 pixels, file size: 403 KB, MIME type: image/png)
Summary
| Description |
English: LY-334370 is a selective 5-HT1F receptor agonist which was under development by Eli Lilly and Company for the treatment of migraine headaches. The drug showed efficacy in a phase II clinical trial but further development was halted due to toxicity detected in animals. |
| Date | |
| Source | Own work |
| Author | Mplanine |
Licensing
I, the copyright holder of this work, hereby publish it under the following license:
This file is licensed under the Creative Commons Attribution-Share Alike 4.0 International license.
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 10:45, 7 November 2022 | | 2,700 × 1,753 (403 KB) | commons>Mplanine | Uploaded own work with UploadWizard |
File usage
There are no pages that use this file.
